NasdaqCM - Nasdaq Real Time Price USD
Traws Pharma, Inc. (TRAW)
1.5100
+0.0400
+(2.72%)
As of 1:14:15 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-29,792
-29,792
-17,932
-16,294
-19,487
Investing Cash Flow
-3,648
-3,648
-14
--
--
Financing Cash Flow
33,976
33,976
--
--
55,560
End Cash Position
21,338
21,338
20,821
38,757
55,070
Capital Expenditure
--
--
-14
--
--
Issuance of Capital Stock
33,976
33,976
--
--
55,041
Free Cash Flow
-29,792
-29,792
-17,946
-16,294
-19,487
12/31/2021 - 7/25/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
INTS Intensity Therapeutics, Inc.
0.9678
-25.55%
VRAX Virax Biolabs Group Limited
1.0640
+2.31%
SCPX Scorpius Holdings, Inc.
0.0680
-48.48%
ENTO Entero Therapeutics, Inc.
0.3640
+0.58%
COCP Cocrystal Pharma, Inc.
1.3700
-2.14%
TOVX Theriva Biologics, Inc.
1.4099
-1.41%
PASG Passage Bio, Inc.
0.3247
-3.36%
CING Cingulate Inc.
4.3360
+2.02%
QTTB Q32 Bio Inc.
1.8700
-1.58%
TSBX Turnstone Biologics Corp.
0.3074
-3.30%